stock listing
T2 Biosystems Regains Compliance With Nasdaq Listing Requirements
In April the firm received notice that it wasn't in compliance because its common stock didn't maintain a minimum bid price of $1.00 for 30 consecutive business days.
Biocept Files $100M Shelf Registration
The company plans to use the proceeds to support a variety of general expenses, including research and development, administration, sales, marketing, and capital expenditures.
Opko to Offer up to $100M of Common Shares
The company will use net proceeds from the offering for R&D, commercialization of its products, working capital, and other business expenses.
Genetic Technologies Out of Compliance With Nasdaq Listing Rules
The company, which also trades on the Australian Securities Exchange, has 45 days to submit a plan to the Nasdaq as to regaining compliance.
Bio-Rad Receives Notice From NYSE for Late Filing of Annual Report
As previously disclosed, Bio-Rad's accounting firm needs more time to complete its audit and the company plans to file the form as soon as possible.